OpenLoop Acquires Hey Revia in AI Healthcare Expansion

What Happened

OpenLoop has acquired Hey Revia, according to a report published by Modern Healthcare. The deal, tracked as part of the outlet's ongoing AI-in-healthcare monitoring series, marks an expansion of OpenLoop's artificial intelligence capabilities within the healthcare services sector.

Background

OpenLoop is a healthcare infrastructure company that provides technology and workforce solutions to health systems, payers, and digital health companies. The company operates as a backend enablement platform, supplying services including clinical staffing, care delivery infrastructure, and health plan administration support to clients building or scaling virtual care programs.

Hey Revia is an AI-focused company operating in the healthcare space. While the Modern Healthcare report does not detail Hey Revia's full product suite, the company has been identified within AI-in-healthcare tracking as a distinct technology vendor, suggesting the acquisition is intended to bring specific AI capabilities in-house at OpenLoop rather than simply expand geographic or client reach.

The acquisition was reported through Modern Healthcare's AI Tracker, a live-update series the outlet maintains to log disclosed deals, product launches, and regulatory developments specifically tied to artificial intelligence adoption across the healthcare industry.

Deal Details

Financial terms of the acquisition were not disclosed in the available wire report. The parties involved have not publicly confirmed a closing date beyond the report's publication window. No regulatory filings or third-party deal valuations were included in the sourced material.

The report does not name a spokesperson or include direct quotes from OpenLoop or Hey Revia executives regarding the strategic rationale for the transaction.

What It Means in Practice

OpenLoop's existing platform sits at the intersection of clinical operations and digital health infrastructure. An acquisition of an AI-native company would represent a shift toward building proprietary AI tooling rather than relying on third-party vendors, a direction several healthcare infrastructure companies have moved in as demand for AI-assisted care coordination, documentation, and patient engagement grows among health system clients.

Hey Revia, based on its identification as an AI healthcare vendor, would likely contribute machine learning or natural language processing capabilities relevant to one or more of those use cases. The specific workflows or clinical applications that Hey Revia's technology addresses have not been confirmed in available sourcing.

The broader market context includes sustained acquisition activity across digital health, where larger platforms have continued consolidating smaller AI point solutions following a period of funding contraction for standalone AI health startups. OpenLoop's move follows a pattern in which infrastructure-layer companies absorb application-layer tools to offer more integrated services to clients.

Industry Setting

The AI-in-healthcare segment has seen multiple disclosed transactions and regulatory actions in recent months. Modern Healthcare's tracker, from which this report is sourced, has recorded a range of activity including product clearances, partnerships, and acquisitions across health systems, insurers, and digital health vendors.

OpenLoop has previously positioned itself as a partner to virtual-first care companies and traditional providers seeking to extend care delivery capacity. Adding AI capabilities through an acquisition would align with that positioning by enabling more automated or AI-assisted clinical and administrative workflows within the same infrastructure layer the company already provides.

No government regulatory review of the OpenLoop and Hey Revia transaction has been publicly disclosed, and the deal does not appear to require FDA clearance based on the information available.

What Comes Next

OpenLoop has not announced a timeline for integrating Hey Revia's technology into its existing platform, and further details on product roadmap or client rollout are expected to be disclosed through official company communications following the close of the transaction.